Menu
Home Explore People Places Arts History Plants & Animals Science Life & Culture Technology
On this page
ATC code N04
Therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System: Anti-parkinson drugs

ATC code N04 Anti-parkinson drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup N04 is part of the anatomical group N Nervous system.

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN04. National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

We don't have any images related to ATC code N04 yet.
We don't have any YouTube videos related to ATC code N04 yet.
We don't have any PDF documents related to ATC code N04 yet.
We don't have any Books related to ATC code N04 yet.
We don't have any archived web articles related to ATC code N04 yet.

N04A Anticholinergic agents

N04AA Tertiary amines

N04AA01 Trihexyphenidyl N04AA02 Biperiden N04AA03 Metixene N04AA04 Procyclidine N04AA05 Profenamine N04AA08 Dexetimide N04AA09 Phenglutarimide N04AA10 Mazaticol N04AA11 Bornaprine N04AA12 Tropatepine

N04AB Ethers chemically close to antihistamines

N04AB01 Etanautine N04AB02 Orphenadrine (chloride)

N04AC Ethers of tropine or tropine derivatives

N04AC01 Benzatropine N04AC30 Etybenzatropine

N04B Dopaminergic agents

N04BA Dopa and dopa derivatives

N04BA01 Levodopa N04BA02 Levodopa and decarboxylase inhibitor N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor N04BA04 Melevodopa N04BA05 Melevodopa and decarboxylase inhibitor N04BA06 Etilevodopa and decarboxylase inhibitor N04BA07 Foslevodopa and decarboxylase inhibitor

N04BB Adamantane derivatives

N04BB01 Amantadine

N04BC Dopamine agonists

N04BC01 Bromocriptine N04BC02 Pergolide N04BC03 Dihydroergocryptine mesylate N04BC04 Ropinirole N04BC05 Pramipexole N04BC06 Cabergoline N04BC07 Apomorphine N04BC08 Piribedil N04BC09 Rotigotine

N04BD Monoamine oxidase B inhibitors

N04BD01 Selegiline N04BD02 Rasagiline N04BD03 Safinamide

N04BX Other dopaminergic agents

N04BX01 Tolcapone N04BX02 Entacapone N04BX03 Budipine N04BX04 Opicapone

N04C Other antiparkinson drugs

N04CX Other antiparkinson drugs

N04CX01 Istradefylline

References

  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020. https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/ATC/index.html

  2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022. /wiki/World_Health_Organization

  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022. https://www.whocc.no/atc/structure_and_principles/

  4. "ATC/DDD Index 2022: code N04". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/?code=N04

  5. "ATCvet Index 2022: code QN04". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/?code=N04